Work Group 4 (WG4) - Post-Market

Chair:	Dr. Ambrose Chi Hong Wong Senior Medical & Health Officer (Medical Device) Medical Device Division Department of Health Hong Kong SAR, China Email: chi_hong_wong@dh.gov.hk	Regulatory Authority
Co-Chair:	Ms. Kitty MAO RA Director GE Healthcare Singapore Email: kitty.mao@ge.com	Industry
Advisor:	Prof. Pei Gao Director, Centre of Real-world Evidence Evaluation (Creation), Peking University Clinical Research Institute Peking University People's Republic of China	Others (Academy)
Member:	Ms. Althea LAU Scientific Officer Medical Device Division Department of Health Hong Kong SAR, China	Regulatory Authority
Member:	Mr. Karl LEUNG Electronics Engineer Medical Device Division Department of Health Hong Kong SAR, China	Regulatory Authority
Member:	Mr. Ahmed Alqami Director of Surveillance Surveillance and Biometrics, Saudi Food and Drug Authority Kingdom of Saudi Arabia	Regulatory Authority
Member:	Ms. Aisha Al-Ghaithi Section Head of Medical Device Vigilance Ministry of Health Muscat, Sultanate of Oman	Regulatory Authority
Member:	Mr. Abdulmohsen Al-Hajlan Post-Market Clinical Evaluation Section Head Saudi Food and Drug Authority Kingdom of Saudi Arabia	Regulatory Authority
Member:	Ms. Sara Alharthi Senior Clinical Evaluation Specialist Saudi Food and Drug Authority Kingdom of Saudi Arabia	Regulatory Authority
Member:	Ms. Xiaoxue Wang Deputy Consultant National Medical Products Administration,Department of Medical Device Regulation People's Republic of China	Regulatory Authority
Member:	Ms. Rui Zhi Medical Device Evaluator Center for Drug Reevaluation, NMPA People's Republic of China	Regulatory Authority
Member:	Ms. Yana Song Medical Device Evaluator Center for Drug Reevaluation, NMPA People's Republic of China	Regulatory Authority
Member:	Mr. Alex CHOI Senior Electronics Engineer Medical Device Division Department of Health Hong Kong SAR, China	Regulatory Authority
Member:	Mr. Dong Li Staff Center for Drug Reevaluation, NMPA People's Republic of China	Regulatory Authority
Member:	Ms. Yan Zhao Deputy Director of Department of Medical Device Monitoring and Evaluation Center for Drug Reevaluation, NMPA People's Republic of China	Regulatory Authority
Member:	Ms. Laleetha DEVI Asia Pacific RAQA Director O&M Halyard Malaysia	Industry
Member:	Ms. Terrenz LEUNG RA & QA Manager Abbott Vascular Hong Kong SAR, China	Industry
Member:	Ms. Carrie LI Regulatory Affairs Supervisor and Quality Assurance Manager Cook Asia Ltd Hong Kong SAR, China	Industry
Member:	Mr. Tony YIP Associate Director Regulatory Affairs APAC Grifols (HK) Limited Hong Kong SAR	Industry
Member:	Dr. Henry Hou Head of Regulatory Affairs, Asia Pacific Elekta Limited Hong Kong SAR, China	Industry
Member:	Ms. Chueh-pin CHEN Team Leader of Division of Drug Safety Taiwan Drug Relief Foundation/ Taiwan National ADR Reporting Center Chinese Taipei	Industry
Member:	Ms. Jacqin Cui Regulatory Affairs Director Abbott People's Republic of China	Industry
Member:	Mr. Wentao WANG Prin. MDR/Vigilance Specialist Medtronic People's Republic of China	Industry
Member:	Ms. Amy Li Senior Vice President of Quality and Regulatory Affairs Guangzhou Wondfo Biotech Co. LTD. People's Republic of China	Industry
Member:	Ms. Lu She Head of QM Siemens Shenzhen Magnetic Resonance People's Republic of China	Industry
Member:	Ms. Wella Wei China RAQA Director Align Technology Co. Ltd. People's Republic of China	Industry
Member:	Ms. Carol LIU Associate Director, IncuBio and Medical Devices, Institute for Translational Research (Biomed Tech) Hong Kong Science and Technology Parks Corporation Hong Kong SAR, China	Industry
Member:	Ms. Huijuan Li Deputy Director, Center for Real -World Evidence Evaluation Peking University Clinical Research Institute People's Republic of China	Others (Academy)
Member:	Prof. Xun Tang Associate Professor Peking University School of Public Health People's Republic of China	Others (Academy)